Case 02: The Thiazide and the Tumble

Session 1 · Classroom case · 12 questions

Andrew Bland, MD, FACP, FAAP · October 2026

Commit to an answer before revealing the explanation. Use the section menu to navigate; each question and answer has its own link. Five-option evidence updates ask for the most defensible direction of change; discuss a justified adjacent response.

Save and export your first responses

First choices and optional confidence stay in this browser and are not sent to the website. Opening an explanation first is recorded. Revisiting an unchanged case preserves the first response; revised cases receive a new version. Website visit analytics are separate. On a shared device, export and clear the history when finished.

Sections in this case
Question and answer links

Session S1 · 2026-10-22 · in-session · 37 min Anchor: Fluids, electrolytes and acid-base — the complete hyponatremia work-up in a thiazide patient · Integrates: hypertension management, medication safety and geriatrics, metabolic alkalosis and urine chloride, magnesium, hypernatremia and the free-water deficit (mirror-image warm-up) One-line hook: A new PA will start a thiazide in an older woman within the first month of practice. This is the patient who comes back three weeks later on a stretcher — and the work-up has to account for every abnormal number on her chemistry panel.

Fictional patient. Every name, date and number in this case is invented for teaching.

Learning Objectives

Answers for this section: Q1 · Q2 · Q3 · Q4 · Q5 · Q6 · Q7 · Q8 · Q9 · Q10 · Q11 · Q12

By the end of this case the student can:

  1. Classify volume status at the bedside from orthostatic vitals, weight change, mucosa, neck veins and lungs, and state which signs are unreliable in a 76-year-old.
  2. Order and read the hyponatremia work-up in sequence: serum osmolality (with the glucose correction), urine osmolality, urine sodium, TSH and cortisol, and a medication review — and explain why a urine sodium measured on a diuretic cannot be read the usual way.
  3. Recognize the thiazide signature (hyponatremia with hypokalemia, metabolic alkalosis and hypomagnesemia), replete magnesium before potassium at safe rates, and use the urine chloride correctly in a patient who has been taking a diuretic.
  4. Decide whether 3% saline is indicated, name the four severe symptoms that indicate it (seizure, coma or obtundation, vomiting, cardiorespiratory distress), and state the 24-hour correction ceiling for a high-risk patient, counting potassium toward it.
  5. Stop the thiazide for good, choose a replacement antihypertensive for a frail older adult, set a standing-BP-aware target, and schedule the BMP that should have been done.

Warm-Up (individual commit before the case)

Answers for this section: Q1 · Q2 · Q3

Three readiness items. Cards up, no discussion, 4 minutes total.

Q1The four branches

Four patients each have a serum sodium of 124 mEq/L and a serum osmolality below 275 mOsm/kg. Match the pattern to the branch of the hyponatremia differential, then answer: which patient has SIADH?

Patient Story Urine osmolality Urine Na Volume exam
1 70-year-old man, three days of vomiting 520 mOsm/kg 12 mEq/L Orthostatic, dry
2 60-year-old woman with small-cell lung cancer 480 mOsm/kg 70 mEq/L Normal — no edema, no orthostasis
3 58-year-old man, twelve beers a day, "doesn't really eat" 80 mOsm/kg 10 mEq/L Normal
4 72-year-old man with heart failure, 3+ leg edema, JVP 10 cm 400 mOsm/kg 10 mEq/L Overloaded

A.

Patient 1

B.

Patient 2

C.

Patient 3

D.

Patient 4

· Link to this question

Correct answer: B

Learning point: The matching runs 1 = hypovolemic (ADH on because the body is dry; the kidney saves sodium, so urine Na is low), 2 = SIADH (ADH on inappropriately in a patient with normal volume, so the kidney does not save sodium and urine Na is high), 3 = low-solute or beer potomania (ADH is off — urine osmolality under 100 means the kidney is diluting as hard as it can, but with almost no solute to excrete it cannot unload the water), 4 = hypervolemic (ADH on because the heart cannot deliver volume to the kidney; sodium is retained, so urine Na is low). SIADH is the only branch that pairs a concentrated urine with a high urine sodium and a normal volume exam — that is Patient 2. Why not the others: Patient 1 has a concentrated urine but is orthostatic with a low urine Na — the ADH is appropriate, not inappropriate. Patient 3 has the one dilute urine of the four — ADH is suppressed, which excludes SIADH by definition. Patient 4 is edematous with a low urine Na — overload, not SIADH. Course reading: Evidence for this case

Evidence and objective for Q1

Back to Q1 · All answers in this case

Q2The urine that is not appropriately dilute

A 66-year-old woman has serum sodium 122 mEq/L and serum osmolality 254 mOsm/kg. Which result best shows impaired excretion of electrolyte-free water and, when renal diluting capacity is intact, ongoing antidiuretic activity?

A.

Urine sodium 60 mEq/L

B.

BUN:creatinine ratio of 24:1

C.

Serum uric acid 3.5 mg/dL

D.

Urine osmolality 410 mOsm/kg

· Link to this question

Correct answer: D

Learning point: Urine osmolality 410 is inappropriately concentrated during hypotonicity. ADH activity is a common explanation, but this is not a direct hormone assay: thiazides and kidney disease can also impair dilution. Use medication history, kidney function, volume findings and the clinical context to determine why the patient cannot excrete the water load. Why not the others: Urine sodium reports the aldosterone system (sodium handling), not the water system. The BUN:creatinine ratio hints at volume, not ADH. A low uric acid is a soft clue toward SIADH but proves nothing about ADH on its own. Course reading: Evidence for this case

Evidence and objective for Q2

Back to Q2 · All answers in this case

Q3The mirror image

An 82-year-old, 50-kg nursing-home resident with advanced dementia has had a fever for three days. She is brought in lethargic. Serum sodium 158 mEq/L, urine osmolality 720 mOsm/kg, blood pressure 118/70 lying, heart rate 102, dry mucous membranes. What is happening, and what is the first step?

A.

Central diabetes insipidus — the pituitary has stopped making ADH; give desmopressin and recheck the sodium in four hours

B.

Nephrogenic diabetes insipidus — the kidney cannot respond to ADH; look for lithium or hypercalcemia and stop the offender

C.

Free-water loss with no access to water — the kidney is concentrating appropriately; replace the deficit slowly by mouth or D5W

D.

Hypervolemic hypernatremia from sodium excess — give furosemide with free water and restrict the dietary sodium for the week

· Link to this question

Correct answer: C

Learning point: This is the most common hypernatremia in the hospital: a patient who cannot get to water (dementia) plus extra free-water loss (fever, insensible loss through skin and lungs). Her urine osmolality of 720 says the kidney is doing its job — ADH is present and the collecting duct is responding — so this is not diabetes insipidus. The free-water deficit: total body water in an elderly woman = 0.45 × 50 kg = 22.5 L; deficit = TBW × (Na/140 − 1) = 22.5 × (158/140 − 1) = 22.5 × 0.129 ≈ 2.9 L. Replace it with water by mouth or feeding tube if she can take it, otherwise D5W, plus her ongoing losses, and bring the sodium down no faster than 10–12 mEq/L in 24 hours (about 0.5 mEq/L per hour) — a brain that has adapted to a high sodium swells if you dilute it too fast. If she were hypotensive you would give isotonic saline first for the circulation and switch to free water once stable. Why not the others: Both forms of diabetes insipidus produce a dilute urine despite a high sodium — the DI pattern is urine osmolality under 300 with a sodium over 150, and that is the pattern CBL-18 (The Lithium Thirst) builds on. Her urine is 720, which excludes both. She has no edema and no sodium load, so hypervolemic hypernatremia does not fit; furosemide would deepen the water deficit. Course reading: Evidence for this case

Evidence and objective for Q3

Back to Q3 · All answers in this case

Part 1 — Presentation

Answers for this section: Q4 · Q5

Setting: Community emergency department, Dubuque, 18:10 on a Tuesday in late October.

Patient: Mrs. Eleanor Voss, a 76-year-old retired school librarian, 49 kg, brought in by ambulance after her daughter found her on the bathroom floor at about 17:15 when she stopped by after work. Mrs. Voss says she got up after lunch to use the toilet, "the room went gray when I stood up," and she sat down hard against the tub. No head strike that she remembers, no loss of consciousness. Her left hip hurts. She has not been able to get up on her own.

History of present illness: Since the water pill started three weeks ago she has eaten less — "nothing tastes right" — and for about two weeks she has lived on tea, toast and broth; for the last two days she has been frankly nauseated and eaten almost nothing. She has not vomited. Her daughter says she has been "muddled" since yesterday: repeating questions, unsure of the day, uncharacteristically slow on the phone. No fever, no cough, no urinary symptoms, no headache, no chest pain, no new weakness on one side.

Past medical history: Stage 2 hypertension, diagnosed three weeks ago (office readings 158/92 and 154/90 at two visits; a week of home readings averaged 148/88). Depression after her husband's death four months ago, treated by her primary care clinic. Knee osteoarthritis. Osteopenia. No diabetes, no heart failure, no kidney disease — three weeks ago her clinic BMP showed Na 137, K 4.1, creatinine 0.8 mg/dL (eGFR 76 mL/min/1.73 m², CKD-EPI 2021), and a CBC the same day showed hemoglobin 12.4 g/dL.

Medications on arrival (reconciled with the pharmacy and the daughter):

Drug Dose Route Frequency Indication Started
Chlorthalidone 25 mg PO once daily, morning Stage 2 hypertension 3 weeks ago (last dose yesterday 08:00; skipped today — nauseated)
Sertraline 50 mg PO once daily Depression (bereavement) 8 weeks ago
Ibuprofen (OTC) 400 mg PO as needed, "most days this week" for the knee Knee osteoarthritis Years, intermittent; daily this week
Acetaminophen 500 mg PO as needed Knee pain Years
Cholecalciferol (vitamin D₃) 1,000 IU PO once daily Osteopenia Years

No potassium supplement. No herbal products. No alcohol ("a glass of wine at Christmas"). Never smoked.

Social history: Lives alone in the house she shared with her husband; daughter visits every other day. Independent with all activities until this week. When chlorthalidone was started she was told to "stay well hydrated with the water pill," and she has been drinking "eight or nine glasses of water a day to be safe."

Vitals: T 36.8 °C · HR 96 supine, 112 standing · BP 128/72 supine, 104/60 after one minute standing (assisted) · RR 16 · SpO₂ 97% on room air · weight 49.0 kg (clinic weight three weeks ago 51.5 kg).

Exam: Thin, alert but slow to answer; oriented to person and place, not to date; follows commands; no dysarthria, no focal weakness, pupils equal and reactive, no neck stiffness. Mucous membranes dry. Neck veins flat at 30°. Lungs clear. Heart regular, no murmur. Abdomen soft. No leg edema. Skin turgor reduced over the forearm. A 6-cm bruise over the left greater trochanter; hip range of motion painful but full; no leg shortening or rotation. Gait not tested.

ED orders already placed when you arrive: CT head without contrast (no acute hemorrhage, no mass; age-appropriate atrophy), left hip and pelvis X-rays (no fracture), ECG, CBC, BMP, serum osmolality, urinalysis and urine osmolality.

First results back (18:40):

Test Result Reference range
Sodium 118 mEq/L 135–145
Potassium 2.8 mEq/L 3.5–5.0
Chloride 74 mEq/L 98–107
Bicarbonate (HCO₃⁻) 34 mEq/L 22–28
Anion gap, Na − (Cl + HCO₃) 10 8–12
BUN 28 mg/dL 7–20
Creatinine 1.1 mg/dL 0.6–1.1 (baseline 0.8 three weeks ago)
BUN:creatinine about 25:1 10–20:1
eGFR not valid — creatinine is moving —
Glucose 108 mg/dL 70–99
Calcium 9.6 mg/dL 8.5–10.5
Serum osmolality, measured 248 mOsm/kg 275–295
Serum osmolality, calculated: 2 × 118 + 108/18 + 28/2.8 252 mOsm/kg gap vs measured −4 (normal <10)
Hemoglobin 13.4 g/dL 12.0–16.0 (12.4 three weeks ago)
White cells 7.2 × 10⁹/L 4.0–11.0
Platelets 230 × 10⁹/L 150–400

ECG: Sinus rhythm 94/min, normal axis, flattened T waves with small U waves in V2–V3, QTc 468 ms, no ectopy, no ST change.

Magnesium, TSH, cortisol and the urine studies are not back yet.

Q4Which way is the water?

You are asked to classify her volume status before the urine studies return. Which bedside finding most strongly supports a hypovolemic branch over a euvolemic (SIADH) branch?

A.

Dry mucous membranes, with a dry and furrowed tongue on inspection of the mouth and lips

B.

Reduced skin turgor over the forearm, the pinched skin recoiling slowly when released

C.

A 24-mmHg systolic fall and a 16-beat heart-rate rise on standing, plus a 2.5-kg weight loss

D.

The absence of leg edema on both sides, with clear lungs on auscultation of both bases

· Link to this question

Correct answer: C

Learning point: Orthostatic blood-pressure and pulse changes, together with measured weight loss, low JVP and the drug history, support volume depletion here. No single physical sign proves the volume state. Orthostasis may also reflect autonomic disease or medications, so it does not automatically exclude coexisting SIADH. BUN:creatinine and hemoconcentration are supportive contextual findings, not definitive volume tests. Why not the others: Dry mucous membranes are nonspecific in an older adult (mouth breathing, anticholinergic drugs, simple thirst). Skin turgor is one of the signs the handouts tell you not to trust in the elderly — the skin has lost its elastic recoil regardless of volume — and the forearm is only the least-bad place to check it. Absence of edema excludes the hypervolemic branch but says nothing about hypovolemic versus euvolemic; SIADH patients have no edema either. Course reading: Evidence for this case

Evidence and objective for Q4

Back to Q4 · All answers in this case

Pause — commit before the reveal

Q5Is it real, and what do you send next?

Her sodium is 118 mEq/L, glucose 108 mg/dL and measured serum osmolality 248 mOsm/kg. Which statement about the next step in the work-up is correct?

A.

Osmolality 248 confirms true hypotonic hyponatremia; send urine osmolality, urine sodium, TSH, cortisol and magnesium, and review every medication

B.

A urine sodium above 30 mEq/L will settle the diagnosis as SIADH, so send that first and skip the osmolalities, the TSH and the cortisol

C.

Order a serum ADH (vasopressin) level — it is the direct test for SIADH — and hold the urine osmolality and urine sodium until the result comes back

D.

The glucose of 108 mg/dL makes this hypertonic (translocational) hyponatremia; correct the sodium to 125 and stop the work-up there

· Link to this question

Correct answer: A

Learning point: Step one of every hyponatremia work-up is to prove the low sodium is a real water problem. A low measured serum osmolality (248) does that: it excludes pseudohyponatremia (a lab artifact from very high lipids or proteins, in which the osmolality is normal) and hypertonic hyponatremia (glucose or mannitol pulling water into the blood, in which the osmolality is high). The glucose correction is worth saying out loud every time: corrected Na = measured Na + 1.6 × (glucose − 100)/100 when glucose is 400 or below — here 118 + 1.6 × 0.08 ≈ 118.1, so the 118 stands. Then the work-up runs in order: urine osmolality (is ADH on?), urine sodium (what is the kidney doing with salt — remembering she is on a diuretic), TSH and cortisol (hypothyroidism and adrenal insufficiency both impair water excretion and must be excluded before anyone says "SIADH"), magnesium (her potassium is 2.8), and a medication review — thiazide, SSRI and NSAID are all on her list. Why not the others: Urine sodium alone cannot diagnose SIADH, and in a patient on a thiazide it cannot be read the usual way at all (Part 3). ADH levels are not used clinically; the urine osmolality is the ADH test. A glucose of 108 is nowhere near the range that moves sodium — hypertonic hyponatremia needs a glucose in the hundreds above normal, and her measured osmolality is low, not high. Course reading: Evidence for this case

Evidence and objective for Q5

Back to Q5 · All answers in this case

Part 2 — Data

Answers for this section: Q6 · Q7 · Q8

At 19:30 the add-on results return.

Test Result Reference range
Magnesium 1.4 mg/dL 1.8–2.4
Phosphorus 3.4 mg/dL 2.5–4.5
Albumin 3.9 g/dL 3.5–5.0
Uric acid 7.1 mg/dL 2.5–6.0 (women)
TSH 2.1 mIU/L 0.4–4.5
Cortisol (drawn 18:30; repeated 07:00 next morning: 21 µg/dL) 19 µg/dL 6–23 (08:00)
Urine osmolality 420 mOsm/kg 50–1,200; <100 expected if ADH were suppressed
Urine sodium, potassium, chloride added on at 19:00 — pending —

Urinalysis: Yellow, clear. Specific gravity 1.013, pH 6.5, protein negative, blood negative, glucose negative, ketones trace, leukocyte esterase and nitrite negative. Microscopy: 0–2 RBC/hpf, 0–2 WBC/hpf, no casts beyond an occasional hyaline cast, no crystals, no bacteria. A bland urine — nothing here points at the kidney itself.

Chest X-ray (for the fall): no infiltrate, no effusion, normal heart size.

Her daughter adds one more thing: "The nurse at the clinic said the water pill could make her potassium low. Nobody said anything about sodium. Her follow-up labs were booked for six weeks."

Pause — commit before the reveal

Q6Which branch is she on?

Serum Na 118, serum osmolality 248, urine osmolality 420 mOsm/kg. She is orthostatic and 2.5 kg down. Chlorthalidone 25 mg was started three weeks ago; sertraline 50 mg eight weeks ago; ibuprofen most days this week. The urine sodium is still pending. TSH and cortisol are normal. What is the best working diagnosis?

A.

SIADH from sertraline — the urine osmolality of 420 proves inappropriate ADH, and SSRIs are the most common drug cause in older women

B.

Thiazide-induced hyponatremia with volume depletion — the orthostasis, the 2.5-kg weight loss and the three-week timeline decide it

C.

Low-solute ("tea-and-toast") hyponatremia — two weeks of broth and toast with nine glasses of water a day that the kidney cannot excrete

D.

Hypervolemic hyponatremia — her hypertension suggests early heart failure, and the raised BUN of 28 fits a congested, underperfused kidney

· Link to this question

Correct answer: B

Learning point: The new thiazide is the leading contributor to hypotonic hyponatremia with potassium, magnesium and chloride depletion. It impairs urinary dilution and can produce sodium loss and hypovolemia; this patient has several findings supporting depletion. Sertraline, NSAID exposure, low solute intake and excess water may contribute. Concentrated urine shows impaired water excretion but is not a direct ADH assay. Why not the others: A may contribute but does not best explain the complete new drug-related pattern. Low solute intake can coexist with concentrated urine when another stimulus to ADH is present; it is not excluded by urine osmolality420. The examination does not support the congested branch. Mixed causes remain possible. Course reading: Evidence for this case

Evidence and objective for Q6

Back to Q6 · All answers in this case

Q7The paired disturbance

K 2.8, HCO₃⁻ 34, Cl 74, Mg 1.4; ECG with flattened T waves, U waves and a QTc of 468 ms; nauseated but not vomiting. Which statement about the pattern and its treatment is correct?

A.

Primary hyperaldosteronism is the leading cause of hypokalemic alkalosis in a hypertensive patient — send aldosterone and renin before giving any potassium, so the result is not confounded

B.

Replace potassium by monitored IV infusion now; defer magnesium until potassium normalizes

C.

Potassium alone will fix this — oral potassium chloride 40 mEq twice daily for a week; a magnesium of 1.4 is only mildly low and can wait for the outpatient visit

D.

The thiazide signature — hypokalemia, chloride-depletion alkalosis and hypomagnesemia; give IV magnesium first or alongside IV potassium in saline on a monitor, and stop the diuretic

· Link to this question

Correct answer: D

Learning point: Read the BMP as a pattern: thiazides waste potassium and magnesium in the distal tubule and waste chloride with the sodium, and volume contraction then makes the kidney hold on to bicarbonate — exactly her panel (K 2.8, HCO₃ 34, Cl 74, Mg 1.4). The alkalosis is the chloride-depletion ("contraction," saline-responsive) type, which fixes itself once chloride and volume are given back and the cause is removed. Magnesium comes first in your thinking because without it the kidney keeps wasting potassium and the potassium you give will not stay in — so start magnesium sulfate 2 g IV over 2 hours first, or alongside the potassium; with a potassium under 3.0 and an ECG change, do not delay the potassium for the magnesium to finish. The potassium goes IV because she is nauseated, under 3.0 and has an ECG change: diluted in isotonic saline (avoid unnecessary dextrose during initial potassium replacement because insulin release can shift potassium into cells), at 10 mEq/h or less through a peripheral line, on a cardiac monitor, with a recheck in 4–6 hours. Why not the others: A delays urgent electrolyte correction and prioritizes a less likely cause before assessing the new thiazide. B and C defer correction of the coexisting magnesium deficit, which can perpetuate renal potassium loss. Replace both under a monitored protocol; concentrated potassium must never be given by IV push. Course reading: Evidence for this case

Evidence and objective for Q7

Back to Q7 · All answers in this case

Pause — commit before the reveal

Q8Does she get 3% saline?

Sodium 118 mEq/L with confusion, GCS 14, no seizure or cardiorespiratory distress. Which initial plan best addresses both cerebral symptoms and volume depletion while limiting overcorrection?

A.

Yes — any sodium under 120 is "severe hyponatremia" and gets a 150-mL bolus of 3% saline over 20 minutes, repeated until the sodium is above 120

B.

Stop the thiazide and NSAID; urgent symptom assessment for a single 3% bolus, cautious volume and Mg/K replacement, and close sodium monitoring

C.

No — she has SIADH from the sertraline, so restrict fluids to 1 L/day, avoid all saline, stop the SSRI tonight and recheck the sodium in the morning

D.

Yes — start a 3% saline infusion at 50 mL/h and run it until the sodium reaches 130, checking the sodium every 6 hours and stopping only at the target

· Link to this question

Correct answer: B

Learning point: Confusion can be a moderately severe symptom of hypotonic hyponatremia. A single 150-mL 3% bolus over 20 minutes is a guideline-supported option when symptoms are attributed to hyponatremia; reassess symptoms and sodium promptly. This is not an instruction to normalize sodium or repeat boluses solely because it is below 120. Stop the causative drugs and address volume and potassium deficits, counting every treatment toward the correction limit. The treating senior clinician selects and documents the monitored protocol. Why not the others: A treats the sodium number as an automatic repeated-bolus trigger; C assumes SIADH despite volume depletion; D targets rapid normalization. B makes symptom treatment and cause treatment part of the same monitored plan. Course reading: Evidence for this case

Evidence and objective for Q8

Back to Q8 · All answers in this case

Part 3 — Course and Decisions

Answers for this section: Q9 · Q10 · Q11

19:45. You stop chlorthalidone and ibuprofen; sertraline is held tonight pending the sodium trend. Magnesium sulfate 2 g IV over 2 hours is started. Because she is orthostatic and 2.5 kg down, you order 1 L of 0.9% saline over 4 hours with potassium chloride 40 mEq added (10 mEq/h), on a cardiac monitor. Oral water is limited to 1 L overnight — not as SIADH treatment, but because she has been drinking nine glasses a day on instruction; the saline, not her water intake, restores volume. The senior clinician reassesses her immediately: orientation improves as treatment begins, so the team chooses close observation rather than a bolus at this point. A single symptom-guided bolus remains a reasonable alternative if confusion persists or worsens. Check sodium every 2 hours during active correction; 3% saline is immediately available for worsening neurologic symptoms.

00:00 (hour 6). The add-on urine electrolytes return: urine sodium 55 mEq/L, urine potassium 28 mEq/L, urine chloride 48 mEq/L. The night resident writes: "UNa 55 with UOsm 420 — consistent with SIADH from sertraline. Suggest fluid restriction, hold saline."

Q9Evidence update

Concordance-style practice: a judgment about how a finding should move your thinking, not a graded test. There is no expert panel behind the key, the teaching explanation. "Unchanged" means the finding does not move the hypothesis — not "I'm not sure."

If you were thinking hypovolemic (thiazide) hyponatremia, and you then learn that her urine sodium is 55 mEq/L, this hypothesis becomes:

A.

Much less likely

B.

Less likely

C.

Unchanged

D.

More likely

E.

Much more likely

· Link to this question

Correct answer: C

Learning point: In a patient who is not on a diuretic, a urine sodium of 55 in hypotonic hyponatremia is a real finding: a dry kidney should be saving every milliequivalent (urine Na under 20–30), so a high value would say the kidney is not short of volume and push you toward SIADH, adrenal insufficiency or a salt-wasting kidney. On a thiazide, the drug forces the kidney to waste sodium whether the body is dry or not — a urine sodium above 30 is the drug's signature, not evidence of euvolemia, so it cannot move the hypothesis in either direction; it is uninterpretable, and the volume exam and the drug timeline decide. That is the conditional part the night resident missed. Two bedside facts settle the case: she was orthostatic and 2.5 kg down, and a thiazide was started three weeks ago in a woman whose sodium was 137 before it — nothing in a urine cup outranks those. What else could it mean, and what would move you: Persistent concentrated urine after the thiazide effect and volume depletion resolve warrants reassessment for SIADH and other causes, including adrenal and thyroid disease. Urine sodium may regain usefulness, but a low or high value is not proof of the earlier volume state. Full recovery from thiazide-associated impaired dilution can take longer than the plasma drug washout. Course reading: Evidence for this case

Evidence and objective for Q9

Back to Q9 · All answers in this case

You decline the fluid-restriction suggestion and keep the plan. The resident asks a fair question back: "Then how fast is too fast?"

04:00 (hour 10). Sodium 125 mEq/L (up 7 from 118). Potassium 3.4, magnesium 1.9. She has had the full liter of saline with 40 mEq KCl and the 2 g of magnesium. She is more alert and knows the month. Urine output over the last two hours: 120 mL/h, up from 60.

Pause — commit before the reveal

Q10The 24-hour ceiling

Ten hours in, her sodium has risen 7 mEq/L. What is the right move now?

A.

Stop the saline, switch the potassium to oral, recheck sodium every 2 hours, watch for a water diuresis, and call nephrology now to prevent further overcorrection

B.

Continue the saline at 100 mL/h with the potassium in it — she is still hypovolemic, and the 24-hour limit applies only to 3% saline, not to isotonic fluid

C.

Give 500 mL of D5W over two hours now to bring the sodium back toward 122, then resume the saline with potassium at half the previous rate

D.

Start fluid restriction at 800 mL/day, continue the potassium chloride in saline, and recheck the sodium at the usual 4-hour interval rather than every 2

· Link to this question

Correct answer: A

Learning point: She is already up 7 mEq/L in 10 hours and is beginning to excrete more water. Stop saline, continue necessary potassium cautiously by mouth, measure sodium every two hours, follow urine output closely and call nephrology now. Hypokalemia and poor intake increase concern for osmotic demyelination; aim for a modest rise and do not exceed 8 mEq/L in 24 hours in this high-risk patient. Specialist-directed desmopressin and/or electrolyte-free water may be needed before the ceiling is crossed. Why not the others: B and D continue treatment that can accelerate correction. C recognizes the relowering option but gives a fixed rescue regimen and then resumes saline without reassessing the trajectory. The immediate goal is to prevent overshoot with a coordinated monitored plan. Course reading: Evidence for this case

Evidence and objective for Q10

Back to Q10 · All answers in this case

06:00 (hour 12). Sodium 126 (up 8). Urine output 260 mL/h, urine osmolality 115 mOsm/kg — the water diuresis has arrived. Nephrology, contacted at 04:00, now directs the sodium plan; they hold it at 126 through hour 24 with free water and a dose of desmopressin — you watch it done, you do not write it.

Day 2. Sodium 130, potassium 3.9, magnesium 2.0, creatinine 0.9. Clear-headed. Standing BP 142/84 with no orthostatic drop. Physical therapy clears her for home with a walker for a week. The dietitian sees her about her two weeks of tea and toast.

Day 3. Sodium 133, HCO₃⁻ 27 — the alkalosis is resolving now that chloride and volume have been given back, which is what a saline-responsive alkalosis does. Repeat urine chloride, now three days off chlorthalidone and on the hospital's 2-g sodium diet: 11 mEq/L — low, as the mechanism predicted, now that the drug is no longer confounding it; the study is consistent with the saline-responsive pattern rather than proof of it. The sertraline question is settled with her and her primary care clinic: the thiazide was the cause, the sodium is correcting with the thiazide gone, and the depression treatment has been helping, so sertraline is restarted with a sodium check in one week and four weeks rather than reflexively abandoned.

Day 4. Sodium 135. Discharge planning turns to the one problem that started all this: her blood pressure is still 140s/80s.

Q11The replacement, the target and the follow-up

At discharge her seated BP is 144/86 and standing 138/82 without symptoms. Chlorthalidone has been stopped. Which plan is best?

A.

Restart chlorthalidone at 12.5 mg daily — the lower dose is safe — with a BMP in one week, and tell her to drink less water this time around

B.

Switch to hydrochlorothiazide 12.5 mg daily — its shorter half-life makes hyponatremia unlikely — with a BMP in two weeks and a standing BP

C.

No antihypertensive — at 76, after a fall, the risks of treatment outweigh the benefits; recheck the pressure in six months and reassess then

D.

Amlodipine 2.5–5 mg daily (or lisinopril), standing BP at every visit, target under 130/80 if tolerated, chart alert: no thiazide rechallenge

· Link to this question

Correct answer: D

Learning point: Avoid another thiazide in this patient after severe symptomatic hyponatremia. Susceptibility can recur on rechallenge; changing to a different thiazide does not reliably remove that risk. Record the adverse effect and select an alternative class with monitoring. Her hypertension is real (stage 2, confirmed by home readings) and the 2025 guideline still treats it at 76; what changes in a frail older adult is how: pick a class without electrolyte effects, start low, titrate slowly, check the standing pressure at every visit, and keep the target of under 130/80 only if she gets there without orthostatic symptoms or a systolic below 110 standing. Amlodipine (a dihydropyridine calcium channel blocker — no sodium, potassium or magnesium effect; watch for ankle swelling) and an ACE inhibitor (lisinopril — needs a BMP at 1–2 weeks for potassium and creatinine) are both first-line classes and both reasonable here; a single agent started low is the frail-adult approach even though stage 2 hypertension would usually start two drugs in a younger patient. Then the system fix: a BMP 1–2 weeks after starting or changing any diuretic — she was booked for six weeks — and written instructions that "stay hydrated" does not mean nine glasses of water. Why not the others: Lower-dose chlorthalidone or hydrochlorothiazide repeats the exposure; the thiazide-safety lecture's own mitigation list puts alternative classes, not dose reduction, first for the highest-risk patients. Untreated stage 2 hypertension at 76 carries a real stroke and heart-failure risk, and the trials that enrolled older adults showed benefit; the fall was from a drug effect, not from treating the pressure. The frail-adult rule is individualize and monitor, not abandon. Course reading: Evidence for this case

Evidence and objective for Q11

Back to Q11 · All answers in this case

Follow-up coverage checkpoint (self-study)

Answers for this section: Q12

Q12Follow-up — little solute, too much water

A different older patient eats mainly tea and toast, drinks 3 L of water daily, and has hypotonic hyponatremia with urine osmolality 85 mOsm/kg. What best explains the low sodium?

A.

Persistent maximal ADH secretion despite a dilute urine

B.

Low dietary solute limits how much water can be excreted

C.

Primary adrenal failure established by this urine result

D.

A high urine sodium proves SIADH despite the diet

· Link to this question

Correct answer: B

Learning point: The dilute urine shows that ADH is largely suppressed. Excreting water still requires enough urinary solute; very little protein and salt can limit water clearance even when the kidney dilutes appropriately. Assess nutrition and intake, correct cautiously, and watch for brisk water diuresis when solute is restored. Why not the others: A conflicts with the dilute urine; C requires clinical and biochemical testing; D cannot diagnose SIADH from urine sodium alone. Course reading: Evidence for this case

Evidence and objective for Q12

Back to Q12 · All answers in this case

Resolution and Teaching Points

Answers for this section: Q1 · Q2 · Q3 · Q4 · Q5 · Q6 · Q7 · Q8 · Q9 · Q10 · Q11 · Q12

Mrs. Voss went home on day 4 on amlodipine 2.5 mg daily, oral potassium chloride 20 mEq daily for one more week, an oral magnesium preparation for two weeks, with the elemental magnesium dose specified and checked by the pharmacist; tolerability and follow-up levels guide the regimen, and acetaminophen for the knee, with the ibuprofen stopped and the reason written down. Sertraline resumed. At her one-week visit: sodium 138, potassium 4.2, magnesium 2.1, creatinine 0.8, seated BP 138/82, standing 132/78, no dizziness. Amlodipine went to 5 mg at four weeks; sodium 139 at four weeks. Her chart carries an allergy-style alert: thiazide-type diuretic — severe hyponatremia 10/2026 — do not rechallenge.

The lesson for a new PA is not that chlorthalidone is dangerous. It is a first-line, outcome-proven drug. The lesson is that in a 49-kg 76-year-old on an SSRI and an NSAID, it was started at a full dose, with no early BMP, and with advice to drink more water — three decisions that each alone would have been survivable.

Clinical Pearl — Urine osmolality says whether ADH is on, never why Urine that is not appropriately dilute shows impaired electrolyte-free water excretion. ADH activity is common, but impaired diluting capacity from drugs or kidney disease can contribute; determine the cause from the whole clinical context.

Clinical Pearl — On a diuretic, the urine electrolytes are the drug talking Diuretics raise urine sodium and chloride and complicate their interpretation. Repeat after the drug effect and volume disturbance resolve if needed; full recovery of diluting capacity after a thiazide can take longer than a few days. A single urine value does not establish SIADH or exclude volume depletion.

Clinical Pearl — Magnesium first, and count the potassium toward the sodium Correct magnesium with potassium; do not delay urgent potassium replacement while waiting for magnesium to finish. Magnesium depletion can perpetuate renal potassium loss. Potassium replacement also contributes to the serum-sodium rise, so include it in the correction plan.

Clinical Pearl — The ceiling is 8, and the danger comes on day 2 For this patient, hypokalemia and poor nutrition favor a conservative ceiling of 8 mmol/L in any 24 hours, with an initial aim near 4–6. Limits differ across guidelines and risk groups; a ceiling is not a target. Water diuresis can begin at any time after treatment removes the stimulus, so follow urine output and sodium closely. Desmopressin and electrolyte-free water may be needed to prevent or reverse overcorrection under specialist guidance.

Clinical Pearl — Never rechallenge, and get the BMP at 1–2 weeks A thiazide that caused hyponatremia is never restarted at any dose or as another thiazide-type drug. Every diuretic start or dose change gets a BMP (sodium, potassium, creatinine) at 1–2 weeks — sooner and more often in the elderly and with an ACE inhibitor or ARB (RAAS blockade) — and the patient is told that "stay hydrated" is not an instruction to push water.

Pitfall — "UNa 55 with UOsm 420: this is SIADH, restrict fluids" The night resident's note. It is the right reading for a euvolemic patient off diuretics and the wrong reading for an orthostatic woman on chlorthalidone. Fluid restriction here leaves her volume-depleted with ADH still on; saline, cautiously, is the treatment. The confounder is the drug, and the fix is to look at the medication table before the urine cup.

Pitfall — Treat attributable symptoms with monitored hypertonic saline; prevent overcorrection by following the response rather than normalizing the number. Confusion attributable to profound hypotonic hyponatremia can justify a monitored 3% bolus. Use symptom severity, reassessment and correction limits; do not reserve hypertonic saline exclusively for seizures or normalize sodium rapidly.

Answers for this section: Q1 · Q2 · Q3 · Q4 · Q5 · Q6 · Q7 · Q8 · Q9 · Q10 · Q11 · Q12

Assigned reading: the explanations in this case and the question-linked course evidence guide. The objective map distinguishes tested decisions from concepts taught in explanations.

Concepts: htn-cardiorenal-04, htn-cardiorenal-06, lytes-01, lytes-04, lytes-05, lytes-06, lytes-08, lytes-09, lytes-10, lytes-11, lytes-18, lytes-25, lytes-27, structural-25.